CCL18 and colorectal cancer: Wu et al.31 reported that CCL18+ macrophages are enriched in metastatic sites of colorectal cancer patients and exhibit an immune-suppressive phenotype and are sensitive to neoadjuvant chemotherapy, emphasizing the crucial role of CCL18+ LAMs in the metastatic microenvironment.